Production (Stage)
Coeptis Therapeutics Holdings, Inc.
COEP
$8.23
-$0.13-1.56%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.87M | -9.81M | -11.62M | -16.14M | -16.31M |
| Total Depreciation and Amortization | 1.09M | 1.05M | 1.04M | 1.04M | 1.04M |
| Total Amortization of Deferred Charges | 166.10K | 216.20K | 150.00K | 150.00K | 150.00K |
| Total Other Non-Cash Items | 1.93M | 2.03M | 2.71M | 6.78M | 6.14M |
| Change in Net Operating Assets | -432.90K | -134.40K | 812.90K | 1.19M | 1.52M |
| Cash from Operations | -7.11M | -6.65M | -6.91M | -6.97M | -7.46M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00K | 0.00 | -100.00K | 250.00K | -100.00K |
| Cash from Investing | 100.00K | 0.00 | -100.00K | 250.00K | -100.00K |
| Total Debt Issued | 1.49M | 1.85M | 2.00M | -890.90K | 2.00M |
| Total Debt Repaid | -582.30K | -651.00K | -937.50K | -1.81M | -1.51M |
| Issuance of Common Stock | 100.00K | 600.00K | 2.25M | 5.79M | 5.79M |
| Repurchase of Common Stock | -500.00K | -500.00K | -500.00K | -450.00K | -- |
| Issuance of Preferred Stock | 9.24M | 3.91M | 3.22M | 1.69M | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 500.40K | 500.00K | 700.00K | 700.00K | 200.00K |
| Cash from Financing | 10.25M | 5.71M | 6.73M | 5.03M | 6.48M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | -- | -- |
| Net Change in Cash | 3.24M | -936.30K | -274.10K | -1.69M | -1.08M |